Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prajnan Das

Showing results (141-150 of 324) with videos related to

Pageof 33
Sort By:
Radiation Oncology (London, England)|October 26, 2006
Concurrent capecitabine and upper abdominal radiation therapy is well toleratedPrajnan Das, Robert A Wolff, James L Abbruzzese, et al.
Practical Radiation Oncology|September 18, 2016
Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractionsCameron W Swanick, Pamela K Allen, Randa Tao, et al.
American Journal of Clinical Oncology|August 4, 2015
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal CanalK Ranh Voong, Asif Rashid, Christopher H Crane, et al.
Clinical Colorectal Cancer|July 28, 2019
A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal CanalCathy Eng, Alexandre A Jácome, Prajnan Das, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgeryMichelle M Kim, Paul F Mansfield, Prajnan Das, et al.
Cancer|June 1, 2007
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapySunil Krishnan, Vishal Rana, Nora A Janjan, et al.
Advances in Radiation Oncology|February 23, 2026
Can Patients With Recurrent or Primary Squamous Cell Carcinoma of the Anus in a Previously Irradiated Pelvis Receive Definitive Reirradiation?Jordan McDonald, Ethan P Damron, Prajnan Das, et al.
Advances in Radiation Oncology|June 6, 2022
Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative AnalysisKelsey L Corrigan, Brian De, Michael K Rooney, et al.
Journal of Surgical Oncology|October 16, 2019
Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancerCasey J Allen, Timothy E Newhook, Timothy J Vreeland, et al.
JCO Oncology Practice|July 2, 2020
Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern ChemoradiationRamez Kouzy, Joseph Abi Jaoude, Daniel Lin, et al.
Pageof 33

Showing results (141-150 of 324) with videos related to

Sort By:
Pageof 33
Radiation Oncology (London, England)|October 26, 2006
Concurrent capecitabine and upper abdominal radiation therapy is well toleratedPrajnan Das, Robert A Wolff, James L Abbruzzese, et al.
Practical Radiation Oncology|September 18, 2016
Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractionsCameron W Swanick, Pamela K Allen, Randa Tao, et al.
American Journal of Clinical Oncology|August 4, 2015
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal CanalK Ranh Voong, Asif Rashid, Christopher H Crane, et al.
Clinical Colorectal Cancer|July 28, 2019
A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal CanalCathy Eng, Alexandre A Jácome, Prajnan Das, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgeryMichelle M Kim, Paul F Mansfield, Prajnan Das, et al.
Cancer|June 1, 2007
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapySunil Krishnan, Vishal Rana, Nora A Janjan, et al.
Advances in Radiation Oncology|February 23, 2026
Can Patients With Recurrent or Primary Squamous Cell Carcinoma of the Anus in a Previously Irradiated Pelvis Receive Definitive Reirradiation?Jordan McDonald, Ethan P Damron, Prajnan Das, et al.
Advances in Radiation Oncology|June 6, 2022
Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative AnalysisKelsey L Corrigan, Brian De, Michael K Rooney, et al.
Journal of Surgical Oncology|October 16, 2019
Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancerCasey J Allen, Timothy E Newhook, Timothy J Vreeland, et al.
JCO Oncology Practice|July 2, 2020
Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern ChemoradiationRamez Kouzy, Joseph Abi Jaoude, Daniel Lin, et al.
Pageof 33